# Mild Hypothermia and Supplemental Magnesium Sulfate Infusion in Severe Traumatic Brain Injury (TBI) Subjects

> **NCT01333488** · PHASE2 · TERMINATED · sponsor: **United States Department of Defense** · enrollment: 6 (actual)

## Conditions studied

- Traumatic Brain Injury

## Interventions

- **DEVICE:** Arctic Sun
- **DRUG:** Magnesium Sulfate

## Key facts

- **NCT ID:** NCT01333488
- **Lead sponsor:** United States Department of Defense
- **Sponsor class:** FED
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-12
- **Primary completion:** 2014-03
- **Final completion:** 2014-06
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Low accrual
- **Last updated:** 2015-10-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01333488

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01333488, "Mild Hypothermia and Supplemental Magnesium Sulfate Infusion in Severe Traumatic Brain Injury (TBI) Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01333488. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*